Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Precision Biosciences Inc
(NQ:
DTIL
)
10.64
-0.29 (-2.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
41,703
Open
10.90
Bid (Size)
10.25 (31)
Ask (Size)
10.75 (58)
Prev. Close
10.93
Today's Range
10.23 - 11.00
52wk Range
0.2750 - 19.43
Shares Outstanding
113,793,338
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Precision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private Placement
May 08, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report First Quarter Results on May 13, 2024
May 07, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Performance
YTD
+2775.68%
+2775.68%
1 Month
-23.12%
-23.12%
3 Month
+2561.33%
+2561.33%
6 Month
+2600.51%
+2600.51%
1 Year
+1181.93%
+1181.93%
More News
Read More
Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
May 07, 2024
From
Precision BioSciences
Via
Business Wire
Earnings Preview: Precision BioSciences
March 26, 2024
Via
Benzinga
Precision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024
May 01, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
April 16, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
DTIL Stock Earnings: Precision BioSciences Misses EPS, Misses Revenue for Q4 2023
March 27, 2024
Via
InvestorPlace
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
March 27, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
March 20, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Presents Preclinical Data Highlighting PBGENE-PMM as a Potential Therapy for Primary Mitochondrial Myopathy
March 19, 2024
From
Precision BioSciences
Via
Business Wire
Earnings Scheduled For March 27, 2024
March 27, 2024
Via
Benzinga
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
March 06, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 01, 2024
Via
Benzinga
SPX, Nasdaq Look To Continue Rally
March 01, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 01, 2024
Via
InvestorPlace
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
March 01, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
February 29, 2024
Via
Benzinga
Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants
February 29, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 27, 2024
Via
Benzinga
Precision BioSciences Announces Non-Exclusive Patent License Agreement with Caribou Biosciences
February 20, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness
February 14, 2024
From
Precision BioSciences
Via
Business Wire
Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations
February 13, 2024
From
Precision BioSciences, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.